Finding 1166789 (2024-007)

Material Weakness Repeat Finding
Requirement
C
Questioned Costs
-
Year
2024
Accepted
2025-12-29

AI Summary

  • Core Issue: Cash draws were made without considering actual expenses incurred, leading to improper cash management.
  • Impacted Requirements: Violations of cash management rules under 2 CFR Part 200 and 45 CFR 75.305 regarding timely fund disbursement.
  • Recommended Follow-Up: Re-establish internal controls to monitor allowable expenditures and ensure cash draws align with qualifying costs.

Finding Text

Finding: Improper cash draws- expenses drawn without regard to expenses incurred. Criteria: Cash Management Per the Office of Management and Budget Compliance Supplement (2 CFR Part 200, Appendix XI), cash management is a relevant compliance requirement for the Unaccompanied Children Program cluster. Per the Notice of Award for all three Unaccompanied Children Funds may be drawn either as a reimbursement, or to accommodate your immediate cash needs. Funds drawn from PMS must not be held in excess of three (3) working days. Drawdown payment requests from PMS must be made consistent with 45 CFR 75.305 – Payment: “(b) …For non-Federal entities other than states, payments methods must minimize the time elapsing between the transfer of funds from the United States Treasury or the pass- through entity and the disbursement by the non-Federal entity whether the payment is made by electronic funds transfer, or issuance or redemption of checks, warrants, or payment by other means”. Condition, Context, and Cause: As discussed above, the Organization was making cash draws from the PMS system without regard to timing of actual allowable expenditures. During our audit, we noted several instances of cash draws in excess of identified expenditures for the period. Result: Amounts identified as unallowable costs per the compliance guidance have been included in the contract liability as disclosed in Note 12. See the Summary of Unallowable Costs and Questioned Costs tables for detail on page 56. Recommendation: The auditors recommend the Organization re-implement internal controls to track allowable expenditures and reconcile qualifying costs with cash draws.

Corrective Action Plan

Cayuga Centers has engaged grants management advisors who will assist in evaluating the scope of these asserted findings in conjunction with Findings 2024-005 and 006 to ensure any perceived deficiencies are addressed to the satisfaction of Cayuga Centers’ primary federal funder. With respect to the drawdown process generally, Cayuga Centers has established a review protocol requiring that draws include only qualified expenditures incurred or expected within three business days. All draw requests require dual approval from both finance and program staff. A centralized draw request log is being maintained, including supporting documentation and reconciliation records. With respect to Finding 2024-008, Cayuga Centers does not entirely agree with the auditors’ assertion that accrued vacation expense was improperly included in draw requests. Under certain circumstances, costs of paid time off may be treated as incurred based on PTO earned, rather than PTO-paid. See 2 C.F.R. § 200.431(b). Cayuga Centers will further evaluate this asserted finding with the grants management advisors described above. To the extent there may be any compliance discrepancy, Cayuga Centers will take further appropriate action.

Categories

Cash Management Allowable Costs / Cost Principles

Other Findings in this Audit

  • 1166741 2024-003
    Material Weakness Repeat
  • 1166742 2024-004
    Material Weakness Repeat
  • 1166743 2024-005
    Material Weakness Repeat
  • 1166744 2024-006
    Material Weakness Repeat
  • 1166745 2024-007
    Material Weakness Repeat
  • 1166746 2024-008
    Material Weakness Repeat
  • 1166747 2024-009
    Material Weakness Repeat
  • 1166748 2024-010
    Material Weakness Repeat
  • 1166749 2024-011
    Material Weakness Repeat
  • 1166750 2024-012
    Material Weakness Repeat
  • 1166751 2024-013
    Material Weakness Repeat
  • 1166752 2024-003
    Material Weakness Repeat
  • 1166753 2024-004
    Material Weakness Repeat
  • 1166754 2024-005
    Material Weakness Repeat
  • 1166755 2024-006
    Material Weakness Repeat
  • 1166756 2024-007
    Material Weakness Repeat
  • 1166757 2024-008
    Material Weakness Repeat
  • 1166758 2024-009
    Material Weakness Repeat
  • 1166759 2024-010
    Material Weakness Repeat
  • 1166760 2024-011
    Material Weakness Repeat
  • 1166761 2024-012
    Material Weakness Repeat
  • 1166762 2024-013
    Material Weakness Repeat
  • 1166763 2024-003
    Material Weakness Repeat
  • 1166764 2024-004
    Material Weakness Repeat
  • 1166765 2024-005
    Material Weakness Repeat
  • 1166766 2024-006
    Material Weakness Repeat
  • 1166767 2024-007
    Material Weakness Repeat
  • 1166768 2024-008
    Material Weakness Repeat
  • 1166769 2024-009
    Material Weakness Repeat
  • 1166770 2024-010
    Material Weakness Repeat
  • 1166771 2024-011
    Material Weakness Repeat
  • 1166772 2024-012
    Material Weakness Repeat
  • 1166773 2024-013
    Material Weakness Repeat
  • 1166774 2024-003
    Material Weakness Repeat
  • 1166775 2024-004
    Material Weakness Repeat
  • 1166776 2024-005
    Material Weakness Repeat
  • 1166777 2024-006
    Material Weakness Repeat
  • 1166778 2024-007
    Material Weakness Repeat
  • 1166779 2024-008
    Material Weakness Repeat
  • 1166780 2024-009
    Material Weakness Repeat
  • 1166781 2024-010
    Material Weakness Repeat
  • 1166782 2024-011
    Material Weakness Repeat
  • 1166783 2024-012
    Material Weakness Repeat
  • 1166784 2024-013
    Material Weakness Repeat
  • 1166785 2024-003
    Material Weakness Repeat
  • 1166786 2024-004
    Material Weakness Repeat
  • 1166787 2024-005
    Material Weakness Repeat
  • 1166788 2024-006
    Material Weakness Repeat
  • 1166790 2024-008
    Material Weakness Repeat
  • 1166791 2024-009
    Material Weakness Repeat
  • 1166792 2024-010
    Material Weakness Repeat
  • 1166793 2024-011
    Material Weakness Repeat
  • 1166794 2024-012
    Material Weakness Repeat
  • 1166795 2024-013
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
93.676 UNACCOMPANIED CHILDREN PROGRAM $5.28M
93.959 BLOCK GRANTS FOR PREVENTION AND TREATMENT OF SUBSTANCE ABUSE $260,463